Navigation Links
Adolor in Medical News

Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinson's Drug Development

...th Carolina Optimization of MOR antagonists for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease Patrick Little, PhD, adolor Corporation, Exton, Pennsylvania TDI is launched bi-annually with applications accepted each spring and fall. It has been enthusiastically re...

BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX

...ay's Trade Alerts include: DUSA Pharmaceuticals Inc. (Nasdaq: DUSA ), MiddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq: NOVA), adolor Corp. (Nasdaq: ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and Abaxis Inc. (Nasdaq: ABAX ). Join investor discussion surrounding these stocks at: ht...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...q: THRX ) United Therapeutics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altu...
Adolor in Medical Technology

GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (Entereg/Entrareg)

LONDON & EXTON, Pa.--(BUSINESS WIRE)--Apr 9, 2007 - GlaxoSmithKline (LSE and NYSE:GSK) and Adolor Corporation (Nasdaq:ADLR) today announced data from Study 767905/014 and provided an update on the clinical development program for alvimopan (Entereg/Entrareg(R)). Study 014, a Phase 3, double bl...
Adolor in Biological Technology

Beacon Equity Issues Technical Trade Alerts on Drug Manufacturer Stocks: FRX, TEVA, AGN, CEPH, VRTX, ADLR

...al Industries Ltd. (Nasdaq: TEVA ), Allergan Inc. (NYSE: AGN ), Cephalon Inc. (Nasdaq: CEPH ), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and adolor Corp. (Nasdaq: ADLR ). Join the fastest growing investment community at: http://www.stockhideout.com See what Cramer has to say about...

Adolor Corporation to Host Investor Conference Call to Report 2008 Financials and Provide an Update on the Launch of ENTEREG(R) (alvimopan)

... EXTON, Pa., Feb. 18 /PRNewswire-FirstCall/ -- adolor Corporation (Nasdaq: ADLR ) today announced that...play will be available for one week. About adolor Corporation adolor Corporation is a biopharmaceutical company special...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...AY INDS INC (Tokyo SE: 3402) TOYOBO CO (Tokyo SE: 3101) VALEANT PHARMACEUTICALS INTL (NYSE: VRX ) HealthShares(TM) Composite Index (HHQ) Drop adolor CORPORATION (NASDAQ: ADLR ) ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN ) ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAP...

Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety

...rgen, Inc.; Centocor, Inc.; OmniCare (formerly IBAH-BioPharm); Pharmacia-Upjohn, and MDS Pharma Services. Dr. Faragasso comes to Premier Research from adolor Corporation where he established and managed a successful and growing safety department over the last 7 years. "We are very pleased to have Dr. Fara...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...asdaq: THRX ) United Therapeutics Corp. (Nasdaq: UTHR ) Valeant Pharmaceuticals Int'l (NYSE: VRX ) Vertex Pharmaceuticals (Nasdaq: VRTX ) Add adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: ALO ) Altus Ph...

NeurogesX Appoints New Director to the Board

...ttle Clinic, a start-up medical care services company. Prior to that, Mr. Peacock served as President and Chief Executive Officer and as a director of adolor Corporation, President, CEO, COO and as a director of Orthovita, Inc., Executive Vice President, Chief Operating Officer and as a director of Cephalon...

The Generic Drug Industry in Illinois

...ide pharmaceuticals for Novartis from 1998 to 2000 and chairman of the Novartis BioVenture Fund, and CEO Andrew Reddick, who was previously the COO of adolor and had been a senior executive with Faulding). It is clear that all these companies and their investors see the potential growth of the U.S. gene...
Other Tags
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... March 28, 2015 Genomic medicine experts ... mesothelioma, revealing, for the first time, key information for ... to read the newly posted story on the ... University of British Columbia, the British Columbia Cancer Agency, ... to reveal underlying molecular alterations and mutations that can ...
(Date:3/28/2015)... 2015 Lately the student-athlete experience ... changes and proposals around the NCAA. In a March ... collegiate student-athletes across a spectrum of universities and sports ... challenges. The special panel consists of athletes who have ... from football, track and field, baseball, and volleyball. They ...
(Date:3/28/2015)... La Mirada, CA (PRWEB) March 28, 2015 ... with ear, nose and throat disorders, are ... Tinnitus is a common issue which is characterized by ... ears. Affecting 1 in 5 people, tinnitus is a ... or disorder and while it is non-fatal, tinnitus can ...
Breaking Medicine News(10 mins):Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2
(Date:3/20/2015)... Mar. 20, 2015 Research and Markets ... of the "India Sensors Market Forecast and ... The sensor market is projected to grow ... Consumer electronics, automotive, industrial and healthcare sectors ... the country. In addition, adoption of MEMS technology ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
Other Contents